Please use a PC Browser to access Register-Tadawul
Get It
FDA to restrict GLP‑1 ingredients used in non‑approved compounded drugs
Hims & Hers Health, Inc. Class A HIMS | 16.73 | +1.70% |
Feb 6 (Reuters) - The U.S. Food and Drug Administration on Friday said it plans to restrict GLP-1 ingredients used in non-approved compounded drugs that companies such as Hims & Hers HIMS.N and other compounding pharmacies have been marketing as alternatives to authorized treatments, citing concerns over quality, safety and potential violations of federal law.
